Biocept, Inc.
5810 Nancy Ridge Drive
San Diego, CA 92121
(858) 320-8200
December 19, 2018
Via Edgar
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:Biocept, Inc.
Registration Statement on Form S-1
File No. 333-228566
Ladies and Gentlemen:
The undersigned hereby withdraws the request for acceleration sent to your office via EDGAR on December 19, 2018, which requested that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement to become effective at 5:25 p.m. Eastern Time on December 19, 2018 or as soon as practicable thereafter.
Sincerely,
Biocept, Inc.
By: /s/ Timothy Kennedy
Timothy Kennedy
Chief Financial Officer
